AP NEWS

Global Biopharmaceutical CMO (Mammalian & Microbial) Market 2018-2023 - ResearchAndMarkets.com

July 24, 2018

DUBLIN--(BUSINESS WIRE)--Jul 24, 2018--The “Global Biopharmaceutical CMO Market - Analysis By Region, By Country: Opportunities and Forecast (2018-2023) -- By Region (North America, Europe, APAC), By Country (U.S, Denmark, Germany, Switzerland, Korea, Japan, China)” report has been added to ResearchAndMarkets.com’s offering.

The global market value is projected to display a steady growth represented by a CAGR of 14.36% during the forecast period of 2018 - 2023.

Amongst the regions, Europe accounts for the largest share by value in global Bio CMO market in 2017. Additionally, Asia Pacific will be a growing region in the forecasted period, 2018-2023 as population is increasing along with growing number of pharmaceutical requirements. Growing number of chronic diseases is also supporting the market of Bio CMO industry.

The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global Bio CMO market. Additionally, the report also assesses the financial performance and strategies of various companies operating in the Biopharmaceutical CMO market.

Scope of the Report

Global Bio CMO Market (Actual Period: 2013-2017, Forecast Period: 2018-2023

Global Bio CMO Market - By value By Type - Mammalian & Microbial

Regional Markets - North America, Europe, APAC (Actual Period: 2013-2017, Forecast Period: 2018-2023)

Bio CMO Market - By value

Country Analysis - U.S, Denmark, Germany, Switzerland, Korea, Japan, China and Others

Bio CMO Market - By value

Other Report Highlights

Market Dynamics - Drivers and Restraints Company Analysis - Lonza, Boehringer Ingelheium, Samsung Biologics, Wuxi Biologics

Key Topics Covered:

1. Research Methodology

2. Executive Summary

3. Biopharmaceutical CMO Market Outlook

4. Global Bio CMO Market: Growth and Forecast

5. Global Biopharmaceutical Market: Segment Analysis

6. North America Bio CMO Market: Growth and Forecast

7. U.S Bio CMO Market, By indications

8. Canada Bio CMO Market , By Indications

9. Europe Bio CMO Market: Growth and Forecast

10. Germany Bio CMO Market, By indications

11. U.K Bio CMO Market, By indications

12. France Bio CMO Market, By indications

13. APAC Bio CMO Market: Growth and Forecast

14. China Bio CMO Market, By indications

15. India Bio CMO Market, By indications

16. Japan Bio CMO Market, By indications

17. Bio CMO Market: Country Analysis

18. Global Bio CMO Market Dynamics

19. Company Profiles

Lonza Boehringer Ingelheium Samsung Biologics Wuxi Biologics

For more information about this report visit https://www.researchandmarkets.com/research/7rvvhw/global?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180724005459/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Biopharmaceuticals ,Pharmaceutical Manufacturing

KEYWORD:

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 07/24/2018 07:42 AM/DISC: 07/24/2018 07:42 AM

http://www.businesswire.com/news/home/20180724005459/en

AP RADIO
Update hourly